Premier Research Group Acquires ARS Inc.
Acquisition Expands Depth and Breadth of Offerings
Premier Research Group plc (AIM: PRG) the international pharmaceutical services group today announced the acquisition of ARS Inc. The acquisition continues the Company’s stated strategy of building an international business both organically and through strategically placed acquisitions.
Commenting on the acquisition, Dr. Simon Yaxley, Chief Executive Officer of Premier Research said: “We are delighted with the opportunity to expand both the depth and breadth of our offering in this way. [ARS] represents a further important step in our strategy of building a leading international contract research organisation.”
Based in the Boston, MA area, ARS will immediately strengthen Premier Research’s presence in the growing New England biotech market. ARS also brings well established capabilities and expertise in Oracle Clinical.
The business is a contract research organisation (CRO) that specialises in clinical data management and Oracle Clinical database services for the pharmaceutical, biotechnology, and medical device industries.
ARS was originally established in 1998 as a clinical research consulting firm focused on clinical monitoring and data management activities. Since its founding, the company has leveraged its success in clinical data management to grow and evolve ARS into a full service contract research organisation. The company has shown consistent and strong revenue growth given its project-based business model and has nearly doubled revenue in the past two years.
Edgemont Capital Partners served as exclusive financial advisor to ARS Inc.
At Edgemont Capital Partners
David K. Blume, Managing Director
Phone: 212-867-8935 Fax: 212-214-0911
Jeff B. Swearingen, Principal
Phone: 212-867-8935 Fax: 212-937-3816